booksshare.net -> -> -> .. -> " " -> 118

- ..

.. , 1962. 711 c.
( ): pharmazeutischewirkstoffe1982.djvu
<< 1 .. 112 113 114 115 116 117 < 118 > 119 120 121 122 123 124 .. 345 >>

Ethoxzolamid
(Etboxyzolamide)
452-35-7
Diureticum
(Carboanhydrase-
Inhibitor);
Glaukom-Mittel
' benzothia2olesulfonamide, 6-ethoxy-
H5Czt4iS>s
XX
4~£thoxyamlin
Schwefei-NH2 kohlensteff
6- Ethoxybenzothiazol-2-thiol (6-Ethoxy-2-mercaptobenzothiazoi)
1 NaOCl 2- NH3
hsc2o~^J_Vs“NH2
6-Ethoxybenzothiazol-
2-suifenarmd
HSC20
—S02— NHs
USP 2868 800 (Upjohn; ert. 1959; Anm. 1954).
D: Redupresin® (Thilo) I; Giaucotensil® (Farmila)
Ethylbiscoumacetat - Ethylestrenol E 375
Ethyl biscou macetat
548-00-5
Anticoagulans;
Antithromboticum
ethyl ester of bis(4-hydroxy-2-oxo-2//-l-benzopyran-3-yl)acetic acid
OH
0\
4-Hydroxy-
cumarin
0
\\
C-COOH
H
Glyoxylsaure
OH <f0OH OH
oeaso
C2H5OH(H2SOb]
COOC2H5 j
OH I OH !
oioio
Ethylbiscoumacetat
USP 2 482 510 (Spojene farmaceuticke Zovody; 1949). USP 2 482 511 (Spojene farmaceuticke Zovody; 1949). USP 2 482 512 (Spojene farmaceuticke Zovody; 1949).
D: Tromexan® (Geigy)
GB: Tromexan® (Geigy)
Ethylestrenol
(Athylestrenol;
Athyloestrenol)
965-90-2
Anabolicum
19-nor-17a-pregn-4-en-17-ol
+ NaBHi
17a-Ethyl-17/3-hydroxy- Natrium -3-oxo- 19-nor-4-androsten borhydrid
1. CHjOH/HCl
2. U/NH3
CH2-CH2 SH SH
Bortn-
fluorid
1. Na/NHs
2. СгОз/НзС-СО-СНз 2 Cfiromtrioxid
Nandrolon (s. S. 619)
1,2-Ethan-
dithiol
CzHsMgBf _
Ethylmagnesium-* Ethylestrenol bromid
Is. auch Lyoestrol-Synthese, S j
376 E Ethylestrenol - Ethylphenacemid - Etidocain
a USP 2878267 (Organon; ert. 1959; N-Prior. 1957). b M. S. de Winter et al., Chem. Ind. (London) 1959,905.
Weiteres Verfahren:
USP 3 112 328 (Organon; ert. 26.11.1963; NL-Prior. 24.8.1956).
F: Orgaboline® (Organon) J: Orgabolin® (Organon-Sankyo)
Orgaboline® infantile (Organon) USA: Maxibolin® (Organon)
GB: Orabolin® (Organon)
Ethylphenacemid 90-49-3 Antiepiiepticum
(Pheneturide)
2-phenyIbutyryIurea
0
DRP 249241 (Bayer; 1910).
S. Kushner etaL, J. Org. Chem. 16, 1283 (1951). Optisch aktive Isomeren:
CH-P 374 644 (Lab. Sapos; Anm. 30.10.1958).
F: Trinuride® (Robert et Carriere)-Komb. GB: Benuride® (Bengue)
I: Lircapil® (Lirca)-Komb.
Lircapil® (Lirca)-Komb.
J: Pheneturide (Sapos-Kodama) Sepotence® Pulv (Kanto)
Etidocain
36637-18-0 36637-19-1 Hydrochlorid
Lokalanastheticum
(±)-2-(A/-ethylpropylamino)-2',6'-butyroxylidide
2-Brombutter
saure
2-Brombutter-
saurechlorid
Etidocain - Etidronat - Etifelmin E 377
(C;HsQhSOz
Oiethytsutfat
^пз
СНз
C3H7
4 , NH-C-CH-N
\—/ || I \
СНз 0 CzHs C2H5 Etidocain
USP 3 812 147 (Astra; ert. 21.5.1974; Prior. 22.12.1970, 19.7.1971).
USP 3 862 321 (Astra; ert. 21.1.1975; Prior. 22.12.1970,19.7.1971,4.3.1974). DOS 2 162 744 (Astra; Anm. 17.12.1971; USA-Prior. 22.12.1970,19.7.1971).
D: Duranest® (Astra) USA: Duranest®(Astra)
Etidocain Astra (Astra)
Etidronat 2809-21-4 Calciumregulator
7414-83-7 Di-Na-Salz
! phosphonic acid, (l-hydroxyethylidene)di-
1 CHjCQOH; 120°C 2. H20;H0cC
li I II HO-P-C-P-OH I I I HO OH OH
Etidronat
DOT 14,104(1978).
FP 1 531913 (Procter■& Gamble; Anm. 19.7.1967; USA-Prior. 20.7.1966).
Weitere Verfahren:
USP 3 366675 (Procter & Gamble; ert. 30.1.1968; Prior. 30.3.1965).
NL-P 6 606 548 (Procter & Gamble; Anm. 12.5.1966; USA-Prior. 13.5.1965).
NL-P 6 610762 (Procter & Gamble; Anm. 29.7.1966; USA-Prior. 29.7.1965,31.5.1966).
F: Didronel® (Beytout) USA: Didronel® (Procter & Gamble)
I: Etidron® (Gentili)
Etifelmin 341-00-4 Antihypotonicum
28599-37-3 Gluconat
1146-95-8 Hydrochlorid
31149-45-8 Nicotinat
2-(diphenylmethylene)butylamine
QH0 C2HS HO C2H5
NaNH, /=\ I I H2/Pt /=\ I I
C=0 + H3CHCH2l2-CN ^J)-C-CH-CN -► ^J)_C-CH-CH2-NH2
d> 6 6
Benzo- Butyronitril
phenon
iQ
С . id ‘
Сгн5
c=c
HCt/H3C-CO0H
ch2-nh2
Etifalmin
378 E Etifelmin - Etilefrin - Etiroxat
DBP 1 122 514 (Giulini; Anm. 8.9.1959).
D: Gilutensin® (Giuiini) J: Tensinase-D® (Nippon Chemiphar)
Etilefrin 709-55-7 Sympathicomimeticum;
943-17-9 Hydrochlorid Kreislaufanalepticum
a-[(ethylamino)methyl]-/w-hydroxybenzyl alcohol
0 0 _ ,0
/=\ // H5C6-C0-C1 . /^v_r/
У // \ Benzoylchlond ’ ХЛ U \ \ V \
/ CH* / CH-5 / CH?~Br
HO 3 H5C6-C0-0 h5c6-co-o
3-Hydroxy- 3-Benzoyloxyacetophenon
acetophenon
0 ! OH
/=\ 0 H2/Raney-Ni | /=\ |
\J~\ ---* ! <\/>-CH-CH2-NH-CjH5
/ ch,-nh-c2h5 1 r~^
HO z i ь H0
3-Hydroxy-o/-ethylamino- ; EUefnn acetophencn
DRP 520 079 (H. Legerlotz; 1926). DRP 522 790 (H. Legerlotz; 1929).
D: Amphodyn®-retard (Klinge)-Komb. Circupon® RR-Kapseln (Tropon) Effortil®/-Depot (Boehringer Ing.) Soledoton® N (Soledum) Tonus-forte-Tablinen® (Sanorania)
F: Effortii® (Boehringer Ing.)
I: Effortii® {Boehringer Ing.)
Tri-Effortil® (Boehringer Ing.) 5. Effortii® (Boehringer-Tanabe) zahlreiche weitere Praparate
Etiroxat
17365-01-4
55327-22-5 Hydrochlorid
Antiarterioskleroticum (Cholesterin- und Lipidsenker)
«-methyl-DL-thyroxine ethyl ester
H3C0
-O-
CHz-C.
CH3
/ ксъи ШсЪСОз
H3C
it-Methoxybenzylmethylketon
НзСО-
HNv^NH

0
5 - (U - Methoxy benzyl I - 5-methylhydantoin
<< 1 .. 112 113 114 115 116 117 < 118 > 119 120 121 122 123 124 .. 345 >>

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

, ?
2009 BooksShare.
.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed